Overview

Inspite of considerable progress in prevention, diagnosis, and treatment, pulmonary embolism has remained a threat to the patient and a challenge for the physician both in conservative, as well as in operative disciplines. Pulmonary embolism is according to pathology observations still the most frequently overlooked clinical diagnosis. In 1-5 per 100 autopsies, clinically unexpected pulmonary emboli are found. In addition, the sequelae of recurrent pulmonary emboli, the syndrome of pulmonary hypertension with or without right heart failure, continues to present a therapeutic dilemma - and no progress is in sight. In intensive care medicine pulmonary embolism, either acute, massive, and/or recur- rent, continues to be both a therapeutic as well as a preventive challenge mobilizing pharmacotherapeutic, catheter-interventional, and operative resources. Diagnostic, therapeutic, and preventive strategies are currently in use. Their basis, however, seems surprisingly thin, as far as our knowledge on the natural course of this chameleon-like illness with and without fibrinolytic, anticoagulative, catheter or opera- tive treatment is concerned. A large European multicenter register has been initiated by Professors Kasper and Geibel with the help of Boehringer Ingelheim Pharmaceutics, in order to better describe the natural course of pulmonary embolism under current treat- ment modalities. Furthermore, recently the clinical significance of the valve patent foramen ovale as a source of paradoxical emboli is beginning to be better understood. Many concepts therefore require revision.

Full Product Details

Author:   A. Geibel ,  Hanjoerg Just ,  W. Kasper ,  S. Konstantinides
Publisher:   Steinkopff Darmstadt
Imprint:   Steinkopff Darmstadt
Edition:   Softcover reprint of the original 1st ed. 2000
Dimensions:   Width: 17.00cm , Height: 1.10cm , Length: 24.40cm
Weight:   0.369kg
ISBN:  

9783642511929

ISBN 10:   3642511929
Pages:   199
Publication Date:   19 May 2012
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   Manufactured on demand  
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Thrombophilia and thrombogenesis.- The molecular mechanisms of inherited thrombophilia.- Hypercoagulative syndrome: Molecular markers for the identification of cardiovascular patients at risk.- Clinical implications of the new understanding of thrombophilia.- The clinical syndrome of acute pulmonary embolism.- Mechanisms of ventilation-perfusion mismatch and hemodynamic alterations in acute and chronic pulmonary embolism.- Clinical course and prognosis of acute pulmonary embolism.- Clinical implications of a patent foramen ovale in patients with massive pulmonary embolism.- The value of echocardiography in the diagnostic work-up of patients with suspected acute pulmonary embolism.- Scintigraphy-ventilation/perfusion scanning and imaging of the embolus.- MR-angiography in the diagnosis of pulmonary embolism.- Anticoagulation and fibrinolysis.- Anticoagulation.- Mechanism of blood coagulation. Newer aspects of anticoagulant and antithrombotic therapy.- Low molecular weight heparins — Pharmacological principles and indications in clinical practice.- Heparin-induced thrombocytopenia.- New developments in the thrombolytic therapy of venous thrombosis.- The risk of recurrent venous thromboembolic disease — implications for treatment.- A randomized trial of the effect of low molecular weight heparin vs. warfarin on mortality in the long-term treatment of proximal vein thrombosis.- Fibrinolysis.- Thrombolytic therapy in pulmonary embolism. Which patients should be treated, which regimen should be used?.- Thrombolytic treatment of pulmonary embolism: Life-saving option or unacceptable risk?.- Surgical treatment of acute pulmonary embolism.

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions